The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 967.00
Bid: 970.00
Ask: 974.00
Change: -8.00 (-0.82%)
Spread: 4.00 (0.412%)
Open: 973.00
High: 981.00
Low: 966.00
Prev. Close: 967.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

30 Nov 2017 07:00

RNS Number : 9120X
CVS Group plc
30 November 2017
 

30 November 2017

CVS Group plc

("CVS" or the "Group")

 

AGM Statement

 

CVS, the UK's leading integrated provider of veterinary services, is holding its AGM at 11.00 a.m. today at which Richard Connell, Chairman, will provide the following update to shareholders:

 

"The Board is pleased to announce that in the four month period ended 31 October 2017 the Group's total sales grew by 20.6% and like-for-like sales1 grew by 4.3% compared to the same period last year.

 

The strong growth in sales of Animed Direct, which we noted in our last results statement, has continued. Excluding Animed Direct, like-for-like sales for the Group grew by 1.5% which, while a slower growth rate than in other recently reported periods, is measured against particularly strong comparators in the previous year which moderate as the current financial year progresses. The like-for-like trends have shown more variance both within and between months than in prior years, making it harder to identify particular trends. The Board believes that the slower like-for-like growth probably reflects the impact on consumers of the greater general uncertainty widely evident in the UK economy and some shortage of clinicians in the UK. Customer loyalty remains high and our healthy pet scheme memberships continue to show excellent growth, at a run-rate in line with the 20%+ level reported at our most recent year end.

 

For many years it has been challenging to recruit veterinary surgeons in the UK. In spite of the fact that CVS believes it is able to offer new recruits the broadest range of career paths and opportunities within the UK industry, we note that these challenges have increased since the vote to leave the European Union. The Group intends to implement a number of measures to encourage more veterinary surgeons and nurses to work for CVS. These measures will include increasing some salaries by more than inflation as well as improving flexible working opportunities. It is intended that any increases in salaries will be funded through price increases.

 

Market consolidation continues and the higher level of acquisition activity evident during our most recent reporting periods has continued. The Group continues to see a large number of opportunities, both in the UK and the Netherlands and anticipates that these markets will remain particularly active. The integration of our recently acquired assets provides strong underpinning for the Group's overall growth expectations as well as affording the opportunity to derive increased benefits from synergies and scale.

 

Since the start of the current financial year on 1 July 2017, the Group has made a total of 13 acquisitions of 21 surgeries bringing the total number of surgeries to 444. The acquisitions were:

 

Practice name

No. ofsites

Main locations

Region & Country

Business

Cundall & Duffy

1

Scarborough

N.E. England

Small & farm animal

StruleVet Services

2

Omagh and County Tyrone

Northern Ireland

Small & farm animal

DierenkliniekWolvega

1

Wolvega

The Netherlands

Small animal

B & W Equine

5

Breadstone, Cardiff, Failand, Stretcholt and Willesley

S.W. England;S. Wales

Equine

Aire

1

Leeds

N England

Small animal, farm animal & equine

DierenkliniekEmmeloord

1

Emmeloord

The Netherlands

Equine

All CreaturesVeterinary Centre

1

Warrington

N.W. England

Small animal

AcornVeterinary Centre

1

Studley

C. England

Small animal

Three ValleysVeterinary

2

Fivemiletown, Irvinestown

Northern Ireland

Small & farm animal

DierenkliniekVrieselaar

1

Lemmer

The Netherlands

Small animal

Buchan Vets

3

Strichen, Peterhead, Fraserburgh

Scotland

Small animal, farm animal & equine

AshburnVeterinary Centre

1

Knighton

S. Wales

Small & farm animal

MS Vets

1

Reading

S.E. England

Small animal

 

 

The total consideration for the above acquisitions was approximately £20.0m.

 

The acquisition of further practices in the UK has continued the geographic development of the Group across the country and has further developed the large animal and equine as well as the small animal businesses. The acquisitions in Northern Ireland bring our total number of sites there to eight whilst the acquisitions in the Netherlands bring our total there to 12. Of particular note is the development of the equine business with the acquisition of B&W Equine in the UK and of Dierenkliniek Emmeloord, our first equine business in the Netherlands.

 

The pipeline of acquisitions remains strong and CVS expects to continue to complete acquisitions in the UK and the Netherlands throughout this year and beyond. Our diverse, integrated model means that acquired businesses not only contribute towards our continuing success, but also benefit from being part of a larger integrated group better able to serve customers' needs."

 

Notes: 

1. Like-for-like sales data comprise revenue generated from all operations compared to the prior year and includes revenue from acquired businesses with effect from the date and month in which it was acquired during the previous year

 

 

Contacts:

CVS Group plc 01379 644 288

Simon Innes, Chief Executive

Nick Perrin, Financial Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell

Liz Yong

James Hopton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBIBDBUDDBGRC
Date   Source Headline
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.